Dr. Susan Love Launches Women’s Health Web Site

OncologyONCOLOGY Vol 14 No 4
Volume 14
Issue 4

At the 1999 San Antonio Breast Cancer Symposium, Dr. Susan Love, noted breast surgeon, author, and patient

At the 1999 San Antonio Breast Cancer Symposium, Dr. Susan Love, noted breast surgeon, author, and patient advocate, announced the launch of her new Internet site, SusanLoveMD.com, focused on Baby Boomer women’s health concerns, with an emphasis on breast cancer.

The site offers in-depth information to assist women and their families in making decisions about breast cancer treatments and other lifestyle choices, such as dealing with menopause. In addition, the web site features comprehensive sections on taking charge of one’s health and living with breast cancer, including information on recurrences, a topic that is seldom addressed. Future plans include discussions on alternative treatments backed by scientific data.

“I am excited about the opportunity to connect with women through the Internet,” said Dr. Love, “I have always believed that each patient is unique, and that information is power for personal decision-making. I hope this site empowers women around the world to make informed choices and ultimately receive better care.”

Frequent Chat Sessions

Leveraging the latest Internet technologies, Dr. Love and other medical experts will host frequent interactive chats. One such session took place during the San Antonio breast cancer meeting.

Monitored bulletin boards are available 24 hours per day for communication among visitors, and Dr. Love and her team will be available for one-on-one e-mail correspondence with SusanLoveMD.com members. A highly anticipated community feature will be up-to-date breakthrough editorials regarding research, recent advances and controversies in the treatment of cancer and mid-life women’s health issues, delivered with Dr. Love’s unique and personal perspective.

Respected for her ability to translate medical jargon into plain English, Dr. Love is well known to the millions of women confronted with breast cancer and menopausal decisions. Recently, she was appointed to the National Cancer Advisory Board by President Clinton. She is the director of the Susan Love MD Breast Cancer Institute in Santa Barbara, California, and an adjunct professor of surgery at University of California, Los Angeles (UCLA). Dr. Love is the co-founder of the National Breast Cancer Coalition (NABCO) and former director of the Revlon/UCLA Breast Center. She is the author of Dr. Susan Love’s Breast Book and Dr. Susan Love’s Hormone Book.

Related Videos
Hope Rugo, MD, speaks to the importance of identifying patients with aromatase inhibitor–resistant, hormone receptor–positive, HER2-negative advanced breast cancer who are undergoing treatment with capivasertib/fulvestrant who may be at a high risk of developing diabetes or hyperglycemia.
Sara M. Tolaney, MD, MPH, describes the benefit of sacituzumab govitecan for patients with HER2-low metastatic breast cancer seen in the final overall survival analysis of the phase 3 TROPiCS-02 study.
An expert from Dana-Farber Cancer Institute describes which patients hormone receptor-positive,  HER2-negative breast cancer will benefit most from treatment with sacituzumab govitecan.
An expert from Dana-Farber Cancer Institute highlights the unmet needs that sacituzumab govitecan meets in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.
An expert from Dana-Farber Cancer Institute highlights data that supported the FDA’s approval of sacituzumab govitecan for advanced hormone receptor–positive, HER2-negative breast cancer.
Experts on breast cancer
Experts on breast cancer
Experts on breast cancer
Hope S. Rugo, MD, an expert on breast cancer
Experts on breast cancer
Related Content